Prostate cancer is one of the popular male genital malignancies worldwide. Several studies have interested on the impact of AMACR expression as indicative and prognostic marker for prostate cancer. Many researches focused on Gleason's score, PSA and bone scintigraphy in diagnosis and prognosis of prostate cancer. Our aim is to explore the immune histochemical expression of AMACR as additional prognostic and predictive marker in prostate cancer. Material and Methods: Immune histo-chemical staining of AMACR on tissue core biopsies of 49 patients with advanced prostatic cancer and evaluated its expression in relation to Gleason's score, initial PSA level, nadir PSA level and bone scan as well as biochemical failure to androgen deprivation therapy. Results: we found statistically significant relation between high AMACR expression and high Gleason's score. Patients with high AMACR expression have a tendency to present with higher level of PSA and positive bone deposits. A tendency was identified for patients with AMACR score 7 to have higher nadir PSA. Biochemical failure was depicted in 71.4% of patients with AMACR Score 7, while patients with AMACR score less than 7 didn't had biochemical failure. On follow up bone scan, ten patients get progression and the AMACR score in these patients was 7. Egyptian J. Nucl. Med., Vol. 15, No. 2, December 2017 53 Conclusion: Our initial results focused on the role of AMACR immune expression as a poor prognostic indicator of prostate cancer, being linked with high Gleason's score, increased incidence of positive bone metastases and initial high PSA level. In addition, the results highlighted the potential role of AMACR expression as predictive marker of hormonal treatment.
INTRODUCTION:
Prostate cancer is one of the popular malignancies in men worldwide, about 220,800 new cases and 27,540 deaths was recorded in 2015 (1) . In Egypt, prostatic cancer is the more common male genital cancer (60.7%) at the NCI, Cairo University in the last decade (2) . Alpha-Methylacyl-CoA-Racemase (AMACR; P504S) has an essential role in the ßoxidation of branched-chain fatty acids and fatty acid derivatives as it catalyzes the transformation of several 2R)-methylbranched-chain fatty acyl-CoAs to their (S)-stereoisomers (3) . The gene for AMACR is located on chromosome 5p13 and encodes a 382 amino acid protein (4) .
The bone is first and main site of metastases in prostatic carcinoma (about 80%), it is considered one of the essential prognostic factors (5, 6) .
Several guidelines consider 99mTc bone scan as the main investigative techniques to identify and monitor bone metastases (7, 8) . Bone scan is done primarily if the PSA is high, the Gleason score is >7 or in symptomatic patients. However, bone scan should be acquired in patients with poorly differentiated tumors and locally advanced disease, regardless of the serum PSA value (8) . The bones scan sensitivity range between 62 and 89% and then it considered acceptable. Androgen ablation by means of castration and/or administration of small chemical inhibitors (e.g., luteinizing hormone-releasing hormone agonists and AR antagonists) is the usual management for advanced prostatic cancer (9) . Several studies have interested on the importance of AMACR expression as an investigative marker for Prostatic carcinoma, especially in context of differential diagnosis with benign prostate mimics (10-15) . 
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MATERILAS AND METHODS:
RESULTS:
Clinico-pathologic data of all patients are listed in When HGPIN partially involved a gland, staining was confined to the HGPIN and did not outspread into the normal epithelial cells within the same gland. In addition, (27) explained that invasive carcinoma and HGPIN together had more immune histo-chemical staining scores than normal prostate epithelium. However, the recorded score for carcinoma was significantly greater than that for HGPIN.
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Comparable results were also stated by Rubin et al. (28) , which mentioned to the role of AMACR in progression of the prostatic cancer. Furthermore, Zha and colleagues (8) suggested that AMACR was functionally important for the progress of Once AMACR protein is expressed, its level remains elevated as the prostatic carcinoma progresses to higher grades and stages and even metastasizes (27) .
A detailed immune histo-chemical analysis utilizing both standard slides and tissue microarrays of samples from 168 primary prostate cancer cases, confirmed that both prostate carcinomas and the presumed precursor lesion (high-grade prostatic intraepithelial neoplasia), had significantly higher score than matched normal prostate epithelium; 88% of the prostate carcinomas had a staining score higher than the highest score observed for any sample of normal prostate epithelium.
Untreated metastases and wide spread bone metastases (n = 32 patients) as well as hormone refractory prostate cancers (n = 14 patients) were generally strongly positive for AMACR (27) . Takahara and colleagues (27) proposed that AMACR inhibition, which may induce 
